Roche Nimblegen, Inc.
Records under this name other than the patents Roche Nimblegen, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,790,543 | Methods and systems for solution based sequence enrichment Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,658,572 | Whole Proteome Tiling Microarrays Formerly held In force · High confidence | In force | High confidence | |
| US 9,346,892 | Methods for Synthesis of an Oligopeptide Microarray Formerly held In force · High confidence | In force | High confidence | |
| US 10,976,317 | Systematic discovery, maturation and extension of peptide binders to proteins Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,268,120 | Identification of Transglutaminase Substrates and Uses Therefor Formerly held In force · High confidence | In force | High confidence | |
| US 10,006,915 | System and method for identification and characterization of transglutaminase species Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,788,495 | System and Method for Identification and Characterization of Transglutaminase Species Formerly held In force · Low confidence | In force | Low confidence | |
| US 10,161,938 | Systematic discovery, maturation and extension of peptide binders to proteins Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,947,272 | BACE1 Inhibitor Peptides Formerly held Lapsed on the fee record Ended Mar 16, 2025 · High confidence | Lapsed on the fee record | Ended Mar 16, 2025 | High confidence |
| US 7,869,959 | Optimized Probe Selection Method Formerly held Lapsed on the fee record Ended Jan 11, 2023 · High confidence | Lapsed on the fee record | Ended Jan 11, 2023 | High confidence |